Maxcyte (MXCT) Total Debt (2020)

Maxcyte's (MXCT) quarterly Total Debt came in at $4.9 million in Q4 2020.

Maxcyte (MXCT) Total Debt (2020) Analysis & Trends

Maxcyte (MXCT) has 1 years of Total Debt data on file, last reported at $4.9 million in Q4 2020.

On a quarterly basis, Total Debt changed N/A year-over-year to $4.9 million in Q4 2020; TTM through Dec 2020 was $4.9 million, a N/A change from a year earlier, with the FY2020 full-year figure at $4.9 million, changed N/A from the prior year.
Total Debt for Q4 2020 stood at $4.9 million.
Over the last five years, Total Debt for MXCT reached as high as $4.9 million in Q4 2020 and fell as low as $4.9 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	183.54 Bn	176.24 Bn	6.27 Bn	34.05 Bn
2	Stryker	129.03 Bn	126.15 Bn	3.81 Bn	14.72 Bn
3	Medtronic	108.43 Bn	99.21 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	68.74 Bn	67.28 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	48.34 Bn	44.67 Bn	1.29 Bn	598.50 Mn
6	Dexcom	28.35 Bn	27.24 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.07 Bn	25.78 Bn	1.98 Bn	10.14 Bn
8	Smith & Nephew	26.89 Bn	26.31 Bn	-	3.18 Bn
9	Koninklijke Philips	24.06 Bn	20.93 Bn	2.07 Bn	9.48 Bn
10	Maxcyte	109.55 Mn	109.55 Mn	8.08 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	4.92 Mn